SCHEMBL6116271

SCHEMBL6116271

Cc1cccc2sc(/C=C/c3c(Cl)cccc3Cl)nc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.47
▸ LMNA P02545 3/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ KMT2A Q03164 6/20 0.40
▸ MAPT P10636 6/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ PKM P14618 2/20 0.40
▸ HPGD P15428 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ AGPAT2 O15120 1/20 0.38
▸ GAA P10253 4/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ PSMB8 P28062 1/20 0.38
▸ POLB P06746 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6116280 1.00 ALDH1A1 (0.47) ALDH1A1LMNAPDE10AKMT2AMAPT
SCHEMBL6115910 0.77 MAPT (0.54) ALDH1A1LMNAKMT2AMAPTMEN1
SCHEMBL6115915 0.77 MAPT (0.54) ALDH1A1LMNAKMT2AMAPTMEN1
SCHEMBL14127134 0.76 ALDH1A1 (0.58) ALDH1A1LMNAKMT2AMAPTMEN1
SCHEMBL22170872 0.74 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AMAPTMEN1
SCHEMBL1747925 0.72 ALDH1A1 (0.61) ALDH1A1LMNAPDE10AKMT2AMAPT
SCHEMBL14127131 0.72 ALDH1A1 (0.61) ALDH1A1LMNAPDE10AKMT2AMAPT
Cyanide SCHEMBL22130198 0.71 ALDH1A1 (0.51) ALDH1A1LMNAKMT2AMAPTMEN1
SCHEMBL31063965 0.69 SNCA (0.52) ALDH1A1KMT2AMAPTMEN1TDP1
SCHEMBL6115942 0.69 ATP4A (0.49) ALDH1A1KMT2AMAPTMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066023-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2024-02-29 — — US disclosed
US-11786520-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIV ANA G MENDEZ INC (US) 2023-10-17 — — US disclosed
US-11311531-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIV ANA G MENDEZ INC (US) 2022-04-26 — — US disclosed
US-20210290615-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2021-09-23 — — US disclosed
US-20200261441-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2020-08-20 — — US disclosed
US-20200246328-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2020-08-06 — — US disclosed
US-10624885-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIV ANA G MENDEZ INC (US) 2020-04-21 — — US disclosed
US-20180214441-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2018-08-02 — — US disclosed
US-9889128-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition Sistema Universitario Ana G. Mendez (PR) 2018-02-13 — — US disclosed
US-20180008590-A9 METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2018-01-11 — — US disclosed
US-20170079973-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2017-03-23 — — US disclosed
WO-2016044636-A2 METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2016-03-24 — — WO disclosed
US-9085574-B2 Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (PR) 2015-07-21 — — US disclosed
EP-2825040-A1 METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS, USING THE COMPOSITION AS CELLULAR MARKERS, AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION. Zayas, Beatriz (US) 2015-01-21 — — EP disclosed
WO-2013059554-A1 METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS, USING THE COMPOSITION AS CELLULAR MARKERS, AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION. ZAYAS BEATRIZ (US) 2013-04-25 — — WO disclosed
US-20120129882-A1 Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (PR) 2012-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786520-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition AHNAK, RECQL, NBAS ALDH1A1 2342/4885LMNA 2005/4885PDE10A 4535/4885
US-11311531-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-20200246328-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-10624885-B2 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-20180008590-A9 METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-20210290615-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition AHNAK, RECQL, NBAS ALDH1A1 2342/4885LMNA 2005/4885PDE10A 4535/4885
US-20120129882-A1 Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition IMMT, BAX, BCL2 ALDH1A1 4511/4885LMNA 514/4885PDE10A 3813/4885
US-20180214441-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-20240066023-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition AHNAK, RECQL, NBAS ALDH1A1 2342/4885LMNA 2005/4885PDE10A 4535/4885
US-20200261441-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885
US-20170079973-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition RECQL, AHNAK, NDUFS1 ALDH1A1 2214/4885LMNA 2275/4885PDE10A 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback